A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition.
J Neural Transm (Vienna). 2003 Nov;110(11):1257-71. doi: 10.1007/s00702-003-0042-6.
J Neural Transm (Vienna). 2003.
PMID: 14628190
Clinical Trial.